Company has no debt since last 5 years. (Source: Standalone Financials)
P&G Health - Procter & Gamble Health Share Price
P&G Health - Procter & ...
P&G Health share price insights
Company witnessed QoQ revenue growth of 12.27%, which is highest in the last 3 years. (Source: Standalone Financials)
Inverted Hammer was formed for P&G Health
Stock gave a 3 year return of -6.04% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
Procter & Gamble Health Ltd. share price moved up by 0.09% from its previous close of Rs 5,203.45. Procter & Gamble Health Ltd. stock last traded price is 5,207.75
Share Price Value Today/Current/Last 5,207.75 Previous Day 5,203.45
Key Metrics
PE Ratio (x) | 43.01 | ||||||||||
EPS - TTM (₹) | 121.08 | ||||||||||
MCap (₹ Cr.) | 8,644.54 | ||||||||||
Sectoral MCap Rank | 41 | ||||||||||
PB Ratio (x) | 16.05 | ||||||||||
Div Yield (%) | 4.99 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.56 | ||||||||||
VWAP (₹) | 5,206.49 | ||||||||||
52W H/L (₹) |
P&G Health Share Price Returns
1 Day | 0.09% |
1 Week | -0.6% |
1 Month | 0.79% |
3 Months | 8.79% |
1 Year | 8.98% |
3 Years | -6.04% |
5 Years | 23.55% |
P&G Health News & Analysis
P&G Health Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
P&G Health Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 12.27%, which is highest in the last 3 years. (Source: Standalone Financials)Topline Contraction
Sales de-grew by 6.5%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 286.01 254.75 315.15 310.98 306.64 Total Income Growth (%) 12.27 -19.17 1.34 1.42 -5.91 Total Expenses 262.98 191.88 215.24 222.75 262.34 Total Expenses Growth (%) 37.05 -10.85 -3.37 -15.09 6.15 EBIT 23.03 62.87 99.91 88.23 44.30 EBIT Growth (%) -63.37 -37.07 13.24 99.16 -43.74 Profit after Tax (PAT) 16.78 46.56 72.07 65.57 29.82 PAT Growth (%) -63.96 -35.40 9.91 119.89 -49.62 EBIT Margin (%) 8.05 24.68 31.70 28.37 14.45 Net Profit Margin (%) 5.87 18.28 22.87 21.08 9.72 Basic EPS (₹) 10.11 28.00 43.40 39.50 17.96 All figures in Rs Cr, unless mentioned otherwise
Insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 794.36 1,101.19 893.72 986.16 1,175.74 Total Assets Growth (%) -27.86 23.21 -9.37 -16.12 -33.18 Total Liabilities 256.12 350.30 277.23 282.45 269.40 Total Liabilities Growth (%) -26.89 26.36 -1.85 4.84 22.82 Total Equity 538.24 750.89 616.49 703.71 906.34 Total Equity Growth (%) -28.32 21.80 -12.39 -22.36 -41.15 Current Ratio (x) 2.39 2.62 2.60 3.04 4.21 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 165.48 258.16 244.23 194.70 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities - 236.00 169.52 247.26 235.37 Net Cash used in Investing Activities - -21.50 -25.54 -32.27 164.64 Net Cash flow from Financing Activities - -98.48 -288.63 -386.63 -883.41 Net Cash Flow - 116.02 -144.65 -171.64 -483.40 Closing Cash & Cash Equivalent - 435.42 319.40 464.05 635.69 Closing Cash & Cash Equivalent Growth (%) 0.00 36.32 -31.17 -27.00 -43.22 Total Debt/ CFO (x) - 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Insights
ROE Outperforming 5 Year Average
Company delivered ROE of 37.34% in year ending Jun 30, 2024 outperforming its 5 year avg. of 29.98%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 37.34 30.55 31.22 25.12 28.03 Return on Capital Employed (%) 51.13 39.50 38.57 31.32 37.41 Return on Assets (%) 25.30 20.83 21.54 17.92 21.61 Interest Coverage Ratio (x) 446.71 445.55 668.74 292.60 0.00 Asset Turnover Ratio (x) 1.21 1.23 1.19 102.28 115.31 Price to Earnings (x) 41.84 38.02 36.23 52.63 26.60 Price to Book (x) 15.57 11.60 11.28 13.20 7.45 EV/EBITDA (x) 25.30 24.12 23.59 33.38 15.91 EBITDA Margin (%) 27.93 27.90 25.20 26.18 28.34
P&G Health Peer Comparison
P&G Health Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -6.04% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -6.04% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of -6.04% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -6.04% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
347.97
Amount Invested (in Cr.)
0.58%
% of AUM
0.25
% Change (MoM basis)
168.88
Amount Invested (in Cr.)
1.93%
% of AUM
0.91
% Change (MoM basis)
UTI MNC Direct-G
Equity: Thematic-MNC
126.13
Amount Invested (in Cr.)
3.93%
% of AUM
1.62
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
P&G Health Board Meeting/AGM
P&G Health Dividends
- Others
Meeting Date Announced on Purpose Details Aug 21, 2024 Jun 28, 2024 Board Meeting Audited Results & Final Dividend May 02, 2024 Mar 27, 2024 Board Meeting Quarterly Results Feb 06, 2024 Jan 12, 2024 Board Meeting Quarterly Results & Interim Dividend Nov 21, 2023 Aug 24, 2023 AGM Rs.50.0000 per share(500%)Final Dividend & A.G.M. Nov 03, 2023 Sep 27, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Special 1500% 150.0 Feb 14, 2024 Jan 26, 2024 Interim 500% 50.0 Feb 14, 2024 Jan 25, 2024 Final 500% 50.0 Nov 23, 2023 Aug 24, 2023 Interim 450% 45.0 Feb 13, 2023 Jan 16, 2023 Final 600% 60.0 - Aug 22, 2024 All Types Ex-Date Record Date Announced on Details Bonus Nov 05, 1991 Dec 12, 1991 Sep 30, 1991 Bonus Ratio: 1 share(s) for every 2 shares held Bonus - - Sep 11, 1986 Bonus Ratio: 3 share(s) for every 5 shares held
About P&G Health
Procter & Gamble Health Ltd., incorporated in the year 1967, is a Mid Cap company (having a market cap of Rs 8,644.54 Crore) operating in Pharmaceuticals sector. Procter & Gamble Health Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue, Scrap and Export Incentives for the year ending 30-Jun-2023. Show More
Executives
Auditors
- ST
Suresh Talwar
Chairman & Ind.DirectorMTMilind Thatte
Managing DirectorLCLokesh Chandak
Executive Director & CFOAAAalok Agrawal
Non Executive DirectorShow More - Haribhakti & Co. LLP
Industry
Key Indices Listed on
BSE 500, BSE 250 SmallCap Index, BSE SmallCap, + 6 more
Address
P&G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),Mumbai, Maharashtra - 400099
More Details
FAQs about P&G Health share
- 1. What's the P&G Health share price today?P&G Health share price was Rs 5,207.75 as on 29 Aug, 2024, 03:51 PM IST. P&G Health share price was up by 0.09% based on previous share price of Rs. 5266.1.
- 2. What is P&G Health's 52 week high / low?52 Week high of P&G Health share is Rs 5,642.85 while 52 week low is Rs 4,636.55
- 3. What's the market capitalization of P&G Health?Within the Pharmaceuticals sector, P&G Health stock has a market cap rank of 41. P&G Health has a market cap of Rs 8,644.54 Cr.
- 4. What is the CAGR of P&G Health?The CAGR of P&G Health is 3.36.
- 5. What are the P&G Health quarterly results?On Standalone basis, P&G Health reported a total income and profit of Rs 286.01 Cr and Rs 16.78 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-06-30 was Rs 1166.89 Cr and Rs 200.98 Cr.
- 6. Who are peers to compare P&G Health share price?Top 6 Peers for P&G Health are Novartis India Ltd., Sanofi India Ltd., AstraZeneca Pharma India Ltd., Pfizer Ltd., GlaxoSmithKline Pharmaceuticals Ltd. and Abbott India Ltd.
- 7. What is the PE & PB ratio of P&G Health?The PE ratio of P&G Health stands at 42.98, while the PB ratio is 16.05.
- 8. What are the returns for P&G Health share?Return Performance of P&G Health Shares:
- 1 Week: P&G Health share price moved down by 0.60%
- 3 Month: P&G Health share price moved up by 8.79%
- 6 Month: P&G Health share price moved up by 2.29%
- 9. Who owns P&G Health?Following are the key changes to P&G Health shareholding:
- Promoter holding has not changed in last 9 months and holds 51.82 stake as on 30 Jun 2024
- Domestic Institutional Investors holding has gone up from 12.3 (30 Sep 2023) to 14.55 (30 Jun 2024)
- Foreign Institutional Investors holding have gone down from 7.38 (30 Sep 2023) to 6.39 (30 Jun 2024)
- Other investor holding have gone down from 28.5 (30 Sep 2023) to 27.23 (30 Jun 2024)
- 10. What dividend is P&G Health giving?Procter & Gamble Health Ltd. announced an equity dividend of 1500% on a face value of 10.0 amounting to Rs 150 per share on 26 Jan 2024. The ex dividend date was 14 Feb 2024.
- 11. Who is the chairman of P&G Health?Suresh Talwar is the Chairman & Ind.Director of P&G Health
- 12. How can I quickly analyze P&G Health stock?Key Metrics for P&G Health are:
- PE Ratio of P&G Health is 43.01
- Price/Sales ratio of P&G Health is 7.28
- Price to Book ratio of P&G Health is 16.05
Trending in Markets
P&G Health Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.